In patients undergoing angioplasty for femoropopliteal disease, use of a paclitaxel-eluting rather than an uncoated balloon can reduce late lumen loss and restenosis at 6 months and lessen the need ...
Randomized Controlled Trial Results Presented At EuroPCR Demonstrate Advantages Over Uncoated Angioplasty Balloons and Drug-Eluting Stents PARIS – Adding to the growing body of evidence on a novel ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback